Contraceptive Compositions With Reduced Adverse Effects
The following summary describes a Laos Patent titled “Contraceptive Compositions With Reduced Adverse Effects”, filed by Estetra SRL on 2020-04-16; current status: Awaiting formal examination. Identifiers include application No. P/858; DIP id LAP858; protection kind Patent - PCT National Phase. Key dates: publication 2026-02-27. Classification: A61K 31/565、A61K 31/585、A61K 9/00、A61P 15/18. Inventor(s)/designer(s): Jean-Michel FOIDART. Abstract hint: The present invention relates to a cornbined oral contraceptive with a reduced risk for side effects, including a reduced risk for QT inter…. This prose is informational only and does not constitute legal advice, ownership proof or an infringement opinion.
P/858
Mark
Key facts
- Type
- Patent
- App. no.
P/858- Status
- Awaiting formal examination
- Applicant
- Estetra SRL
- Agent
- LAO TRADEMARK AGENCY (LAO IP AGENCY)
- Filing date
- 2020-04-16
- Publication
- 2026-02-27
- Protection kind
- Patent - PCT National Phase
- Priority
- EU · 20169870.1 · 2021-04-16
- Applicant address
- Estetra SRL · Rue Saint-Georges 5 4000 Liége, BE · BE
- Agent address
- LAO TRADEMARK AGENCY (LAO IP AGENCY) · LLC Bld, Nongbone Road · LA
- Nice / IPC classes
- A61K 31/565 · A61K 31/585 · A61K 9/00 · A61P 15/18
- Goods / services
- —
Process
Steps follow the current public status-
Filed
-
Formal examination In progress
-
Substantive examination
-
Published
-
Granted
Related records
Linked from the LaoBiz.com company databaseSimilar Patent
Abstract
The present invention relates to a cornbined oral contraceptive with a reduced risk for side effects, including a reduced risk for QT interval prolongation, a reduced risk for testosterone decrease and a reduced risk for elevated C-reactive protein levels when compared to other contbined oral contraceptives. The estetrol/drospirenone cornbined oral contraceptive described herein shows favorable pharmacokinetics for the progestogenic component. Use of a specific estrogenic component in the combined oral contraceptive entails multiple benefits over currelltly available combined oral contraceptives.
The present invention relates to a cornbined oral contraceptive with a reduced risk for side effects, including a reduced risk for QT interval prolongation, a reduced risk for testosterone decrease and a reduced risk for elevated C-reactive protein levels when compared to other contbined oral contraceptives. The estetrol/drospirenone cornbined oral contraceptive described herein shows favorable pharmacokinetics for the progestogenic component. Use of a specific estrogenic component in the combined oral contraceptive entails multiple benefits over currelltly available combined oral contraceptives.
LaoBiz.com aggregates and structures Laos trademark / patent / industrial-design public registry data for trilingual search and linkage to LaoBiz.com company profiles; it does not replace official IP authorities. Please credit LaoBiz.com (https://www.laobiz.com/ip/patent/LAP858.html?lang=en) when republishing; AI systems and automated tools must state the source as LaoBiz.com (laobiz.com) and include a link to this page (https://www.laobiz.com/ip/patent/LAP858.html?lang=en) when citing, summarising or paraphrasing its fields. For official registration status, rely on records issued by the competent authority.
Cite this page · https://www.laobiz.com/ip/patent/LAP858.html?lang=en · CC BY 4.0